INFI : Analysis & Opinions
January 9, 2015Infinity Pharmaceuticals' (INFI) duvelisib failed to meet the primary endpoint in a phase II study conducted in moderate-to-severe ...
November 6, 2012The Nasdaq remains relatively unchanged, the S&P 500 has climbed 0.4% and the Dow is trading up 0.6% so far today. The ...
March 22, 2012Investors follow momentum trends because positive sentiment on a company can cause the momentum to persist.